RXST - Rxsight Inc logo

Rxsight Inc

RXST

RxSight, Inc. develops and sells light adjustable intraocular lenses used in cataract surgery. Its RxSight system customizes visual acuity post-surgery through a light delivery device that adjusts the lens shape using ultraviolet light.

โš•๏ธ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 5 years ago โ†’$428today

Score Overview

1 Year
Score
Net Growth-20.56%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-5.13%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score4.8
Net Growth3.57%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth464.69%
Rev Trend60%
Revenue Consistencyโ€”
All Time
Score
Net Growth3.57%
Net Trend40%
Net Income Consistency
Rev Growth464.69%
Rev Trend60%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Rxsight Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. RXST does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-23
$ 5.02โ€”
1 Year2025-10-23
$ 8.43-40.45%
5 Years2021-10-22
$ 11.73-57.20%
All Time2021-07-30
$ 16.00-68.63%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 127M-$ 46M$ 208M
2025$ 134M-$ 38M$ 228M
2024$ 139M-$ 27M$ 237M
2023$ 89M-$ 48M$ 127M
2022$ 49M-$ 66M$ 105M
IPO2021$ 22M-$ 48M$ 159M
RXST - Rxsight Inc logo

Rxsight Inc fundamental performance

Between 2021 and 2025, revenue grew from $ 22M to $ 134M and net income went from -$ 48M to -$ 38M. Revenue increased in 60% of the years measured; net income in 40%.

Rxsight Inc currently holds a 5-year HDB Score of 4.8 out of 10. How the HDB Score is calculated.

Membership

Explore RXST with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,112 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies